Dequilla, Jesus M.
HRN: 18-20-27 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2023
METRONIDAZOLE 500MG (TAB)
05/02/2023
05/11/2023
NGT
500mg
TID
Sepsis, FOBT Positive
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes